Worth a Try –

Sept. 19, 2018 – A University of Maryland medical research institute has been tapped to test a promising opioid addiction treatment that aims to curb the cravings that are often responsible for relapses but not controlled well by other common therapies. The Institute of Human Virology, a center in the school of medicine that normally focuses on infectious diseases, plans to announce today that it has won a $12 million federal grant to investigate the therapy over the next five or six years. The institute will test the drug for Amygdala Neurosciences Inc., a California-based biopharmaceutical firm, along with the National Institutes of Health, which provided the funding. The effort is part of a NIH new program launched in April to speed scientific solutions for the national opioid addiction and overdose epidemic called the Helping to End Addiction Long-term, or HEAL, Initiative.

Full Story @ BaltimoreSun.com